Esperion Therapeutics, Inc. · NASDAQ:ESPR

Wasatch Advisors LP reported a 6.10% stake in Esperion Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 22, 2026

Wasatch Advisors LP reported a 6.10% stake in Esperion Therapeutics, Inc., 15,768,897 shares, as a passive investor on Mar 31, 2026. Filed Apr 22, 2026 (Schedule 13G).

Stake
6.10%
Shares
15,768,897
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Wasatch Advisors LP6.10%15,768,897

Source

View original at SEC

Related